Dr Reddys Laboratories Share Price Today - Live Blog for June 30, 2025

Following a noteworthy 0.23% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,286.90. When it comes to valuation, this stock has a PE ratio of 19.2000, with the industry PE ratio at 34.7986.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.03% drop, and it's now trading at ₹1,283.75 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a substantial 0.01% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,283.35, making it an appealing option for investors.

With a -0.04% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,283.20. Investors should examine the factors driving this decline. The stock's PE ratio is 19.2000, whereas the industry PE ratio stands at 34.7986.

Dr Reddys Laboratories Ltd displayed no price movement, holding steady at ₹1,284.80. Interestingly, the stock maintains a Price-to-Earnings (PE) ratio of 19.2000, while the industry PE ratio stands at 34.7986, which might influence investors' decisions.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.19% in its share price, and it currently trades at ₹1,284.80 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.06%, reaching the current market price of ₹1,286.70. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a -0.09% decrease in its share price, and it is currently trading at ₹1,285.90. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.2000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.41%, and as of now, it's trading at ₹1,287.20 per share. This upward trajectory is attracting keen interest from investors.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.10% upswing and is currently trading at ₹1,281.90, indicating strong market sentiment.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.02% upswing, and it's currently trading at ₹1,280.00 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd is facing a -0.02% decline and is currently trading at ₹1,279.70 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd share price surged by 0.08%. With its current market price standing at ₹1,281.20 per share, this stock is garnering increased attention from the investment community.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.18% boost, with the current market value at ₹1,280.20 per share. This surge has not gone unnoticed by investors.

The share price of Dr Reddys Laboratories Ltd experienced a -0.10% slump and is currently trading at ₹1,276.80. While the stock maintains a PE ratio of 19.2000, the industry PE is 34.7986, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.02% upswing and is currently trading at ₹1,278.60, indicating strong market sentiment.

With a -0.23% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,278.00. The stock is currently trading at a PE of 19.2000, while the industry PE is 34.7986, prompting investors to assess its value proposition.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.14% upswing and is currently trading at ₹1,276.80, indicating strong market sentiment.

With a -0.15% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,277.05. The stock is currently trading at a PE of 19.2000, while the industry PE is 34.7986, prompting investors to assess its value proposition.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.10%, reaching the current market price of ₹1,278.60. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.26%, and as of now, it's trading at ₹1,277.85 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.01%, reaching the current market price of ₹1,275.75. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd suffered a -0.67% decline, and it currently trades at ₹1,276.10 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has fallen by -0.42%, a situation worth noting. At present, the stock is trading at ₹1,285.20. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.2000, while the industry PE ratio is 34.7986.

Dr Reddys Laboratories Ltd observed a -0.22% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,298.25. The stock has a PE ratio of 19.2000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.22% in its share price, and it currently trades at ₹1,298.25 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.